Skip to main content

Origin and stepwise evolution of vertebrate lungs.

Nature ecology & evolution2025-02-15PubMed
Total: 90.0Innovation: 9Impact: 9Rigor: 9Citation: 9

Summary

Cross-species single-cell and regulatory analyses show that much of the genetic program for lungs existed before the emergence of bony fish, with later acquisition of lung-specific enhancers and mammal-specific alveolar innovations. Alveolar type 1 cells are mammal-specific, and sfta2 deletion causes severe respiratory defects in mice, establishing function for a new lung gene.

Key Findings

  • Single-cell analyses across vertebrates reveal conserved lung cell programs and trajectories despite organ absence in cartilaginous fishes.
  • Many lung enhancers and lung-related gene coexpression patterns are present in cartilaginous fishes, indicating an ancestral regulatory foundation.
  • Alveolar type 1 cells are mammal-specific, with mammal-specific genes (e.g., ager, sfta2) highly expressed in lungs.
  • Functional deletion of sfta2 in mice causes severe respiratory defects, demonstrating essential gene function in mammalian lung.

Clinical Implications

While not immediately clinical, defining mammal-specific alveolar programs and essential genes (e.g., sfta2) may inform congenital lung disease mechanisms and regenerative strategies targeting alveolar cell types.

Why It Matters

This work reframes the origin of lung developmental programs and identifies a mammal-specific alveolar cell type and essential gene, providing a unifying evolutionary and mechanistic blueprint for lung biology.

Limitations

  • Exact species numbers and developmental stages per species are not detailed in the abstract
  • Regulatory inferences from enhancer conservation require further causal testing across taxa

Future Directions

Dissect regulatory enhancer function across non-mammalian models; map lineage trajectories with spatial multi-omics; translate mammal-specific alveolar programs to inform lung regeneration and disease.

Study Information

Study Type
Basic/mechanistic study
Research Domain
Pathophysiology
Evidence Level
V - Preclinical comparative genomics and functional validation in animal models
Study Design
OTHER